Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 570

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial

Open access
Andrade, Jason G., Champagne, Jean, Dubuc, Marc, Deyell, Marc W., Verma, Atul, Macle, Laurent, Leong-Sit, Peter, Novak, Paul, Badra-Verdu, Mariano, Sapp, John, Mangat, Iqwal, Khoo, Clarence, Steinberg, Christian, Bennett, Matthew T., Tang, Anthony S.L., Khairy, Paul, For the CIRCA-DOSE Study Investigators, Parkash, Ratika, Guerra, Peter, Dyrda, Katia, Rivard, Lena, Racine, Normand, Sterns, Lawrence, Leather, Rick, Seifer, Colette, Jolly, Umjeet, Raymond, Jean-Marc, Roux, Jean-Francois, Nault, Isabelle, Sarrazin, Jean-Francois, Ramanathan, Krishnan, Cheung, Christopher, Fordyce, Christopher, McKinney, Jimmy, Luong, Christina, Rizkallah, Jacques, Angaran, Paul, Ha, Andrew, Glover, Benedict, Skanes, Allan, Gula, Lorne·2019·Circulation

Abstract

Background: Advanced generation ablation technologies have been developed to achieve more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial fibrillation (AF) ablation. Methods: We randomly assigned 346 patients with drug-refractory paroxysmal AF to contact force–guided radiofrequency ablation (CF-RF; n=115), 4-minute cryoballoon ablation (Cryo-4; n=115), or 2-minute cryoballoon ablation (Cryo-2; n=116). Follow-up was 12 months. The primary outcome was time to first documented recurrence of symptomatic or asymptomatic atrial tachyarrhythmia (AF, atrial flutter, or atrial tachycardia) between days 91 and 365 after ablation or a repeat ablation procedure at any time. Secondary end points included freedom from symptomatic arrhythmia and AF burden. All patients received an implantable loop recorder. Results: One-year freedom from atrial tachyarrhythmia defined by continuous rhythm monitoring was 53.9%, 52.2%, and 51.7% with CF-RF, Cryo-4, and Cryo-2, respectively ( P =0.87). One-year freedom from symptomatic atrial tachyarrhythmia defined by continuous rhythm monitoring was 79.1%, 78.2%, and 73.3% with CF-RF, Cryo-4, and Cryo-2, respectively ( P =0.26). Compared with the monitoring period before ablation, AF burden was reduced by a median of 99.3% (interquartile range, 67.8%–100.0%) with CF-RF, 99.9% (interquartile range, 65.3%–100.0%) with Cryo-4, and 98.4% (interquartile range, 56.2%–100.0%) with Cryo-2 ( P =0.36). Serious adverse events occurred in 3 patients (2.6%) in the CF-RF group, 6 patients (5.3%) in the Cryo-4 group, and 7 patients (6.0%) in the Cryo-2 group, with no significant difference between groups ( P =0.24). The CF-RF group had a significantly longer procedure duration but significantly shorter fluoroscopy exposure ( P <0.001 vs cryoballoon groups). Conclusions: In this multicenter, randomized, single-blinded trial, CF-RF and 2 different regimens of cryoballoon ablation resulted in no difference in 1-year efficacy, which was 53% by time to first recurrence but >98% burden reduction as assessed by continuous cardiac rhythm monitoring. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01913522.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.119.042622

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 570

Metadata

Authors
Andrade, J. G., Champagne, J., Dubuc, M., Deyell, M. W., Verma, A., Macle, L., Leong-Sit, P., Novak, P., Badra-Verdu, M., Sapp, J., Mangat, I., Khoo, C., Steinberg, C., Bennett, M. T., Tang, A. S. L., Khairy, P., For the CIRCA-DOSE Study Investigators, Parkash, R., Guerra, P., Dyrda, K., Rivard, L., Racine, N., Sterns, L., Leather, R., Seifer, C., Jolly, U., Raymond, J.-M., Roux, J.-F., Nault, I., Sarrazin, J.-F., Ramanathan, K., Cheung, C., Fordyce, C., McKinney, J., Luong, C., Rizkallah, J., Angaran, P., Ha, A., Glover, B., Skanes, A., & Gula, L.
Venue
Circulation
Published
2019-11-26
Volume
140
Issue
22
Pages
1779-1788
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2981584498
Cited by
570
References
25
FWCI
43.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1161/circulationaha.119.042622
The paper
Andrade, J. G., Champagne, J., Dubuc, M., Deyell, M. W., Verma, A., Macle, L., Leong-Sit, P., Novak, P., Badra-Verdu, M., Sapp, J., Mangat, I., Khoo, C., Steinberg, C., Bennett, M. T., Tang, A. S. L., Khairy, P., For the CIRCA-DOSE Study Investigators, Parkash, R., Guerra, P., . . . Gula, L. (2019). Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. Circulation. https://doi.org/10.1161/circulationaha.119.042622

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.